Patent Law Weblog
recent posts
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
about
Category: Biotech/Pharma News
-
"Biotech/Pharma" Top 47 By Donald Zuhn — The Intellectual Property Owners Association (IPO) released its 25th annual list of the top 300 organizations receiving U.S. patents. Readers may recall that the U.S. Patent & Trademark Office stopped releasing its annual list of top patent recipients in 2006 in order to "discourag[e] any perception…
-
By Donald Zuhn — Last week, both The Washington Post and Nature News reported on the efforts of biotech companies to secure patents directed to gene-altered crops that are designed to withstand the effects of global warming. The impetus behind both articles was a 30-page report entitled "Patenting the ‘Climate Genes’ . .…
-
By Kevin E. Noonan — An important consequence of the biotechnology revolution has been an increased understanding of the molecular biology of cancer. Tyrosine kinases, including the eponymous src oncogene, provide important targets, comprising a family of plasma membrane proteins that in certain incarnations act as growth factor receptors. Until now, therapeutic agents…
-
By Kevin E. Noonan — Ever since it was discovered by European explorers at the end of the 18th Century, the duckbill platypus (Ornithorhynchus anatinus) has been a biological anomaly. Fur-bearing and lactating like a mammal (although lactation is through the abdominal wall because the animal lacks nipples), the platypus reproduces by egg-laying…
-
By Kevin E. Noonan — In retrospect, it was eerily prescient. The Wall Street Journal published an article Saturday, hours before the tragedy at Churchill Downs where Eight Belles, a two-year old filly was euthanized because she broke both front ankles after finishing second in the Kentucky Derby. That article was about the…
-
By Kevin E. Noonan — Gina Kolata identifies the villain of her recent piece in The New York Times on rising drug costs in the first sentence: "[h]ealth insurance companies" that have changed their reimbursement and prescription drug coverage for certain high-priced drugs (see "Co-Payments Soar for Drugs With High Prices"). But that…
-
By Mark Chael — On April 8th, Antigenics Inc. announced that the Russian Ministry of Public Health had approved Oncophage® for the treatment of intermediate-risk kidney cancer. According to Antigenics, Oncophage® is derived from a discrete tumor and contains the antigenic fingerprint of the cancer cells that make up that particular tumor, making…
-
By Donald Zuhn — StemCellPatents.com has announced the launch of a newly redesigned stem cell patent database. A beta version of the database was launched in November 2006. The stem cell patent database will extend the site’s other offerings, which include online news, a weekly e-mail newsletter, the SCP Journal, and a jobs…
-
By Donald Zuhn — Last Thursday, Rep. Anna Eshoo (D-CA; at right) introduced a new biologics bill in the House. The bill (H.R. 5629), which would amend Section 351 of the Public Health Service Act to create a regulatory pathway for biosimilars, has been referred to the Committee on Energy and Commerce and…
-
By Kevin E. Noonan — The two remaining ex parte re-examinations (35 U.S.C. § 302-307) of Wisconsin Alumni Research Foundation (WARF) stem cell patents — Control No. 90/008102 for U.S. Patent No. 5,843,780 (claiming primate embryonic stem (pES) cells) and Control No. 90/008139 for U.S. Patent No. 6,200,806 (claiming human embryonic stem cell…
Patent Docs 